New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - cisapride monohydrate 30mg - suppository - 30 mg - active: cisapride monohydrate 30mg

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - cisapride monohydrate 10mg equivalent to 10.387 mg cisapride monohydrate.;   - tablet - 10 mg - active: cisapride monohydrate 10mg equivalent to 10.387 mg cisapride monohydrate.   excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch microcrystalline cellulose polysorbate 20 povidone purified water

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - cisapride monohydrate 5mg;   - tablet - 5 mg - active: cisapride monohydrate 5mg   excipient: lactose monohydrate magnesium stearate polysorbate 20

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - cisapride monohydrate 20mg;   - tablet - 20 mg - active: cisapride monohydrate 20mg   excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch microcrystalline cellulose polysorbate 20 povidone purified water

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - cilazapril monohydrate 5.22mg equivalent to 5.0 mg cilazapril, anhydrous;  ; hydrochlorothiazide 12.5mg;  ;  ;   - tablet - active: cilazapril monohydrate 5.22mg equivalent to 5.0 mg cilazapril, anhydrous   hydrochlorothiazide 12.5mg       excipient: hypromellose   iron oxide red lactose monohydrate maize starch purified talc   sodium stearyl fumarate titanium dioxide - the treatment of patients with hypertension who are not adequately controlled on monotherapy

Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - moxifloxacin hci, anhydrous - solution for infusion - 400/250 mg/ml - fluoroquinolones

Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - moxifloxacin hci, anhydrous - solution for infusion - 400/250 mg/ml - fluoroquinolones

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

cardinal health - tacrolimus anhydrous (unii: y5l2157c4j) (tacrolimus - unii:wm0haq4wnm) - tacrolimus anhydrous 1 mg

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - paroxetine hydrochloride anhydrous (unii: 3i3t11ud2s) (paroxetine - unii:41vrh5220h) - paroxetine 10 mg - paroxetine tablets are indicated for the treatment of major depressive disorder. the efficacy of paroxetine in the treatment of a major depressive episode was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical pharmacology, clinical trials ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the effects of paroxetine in hospitalized depressed patients have not been adequately studied. the efficacy of paroxetine in maintaining a

Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - azithromycin anhydrous - film-coated tablet - 250 milligram(s) - macrolides; azithromycin